Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001401708-21-000120)

Filing Details

Accession Number:
0001401708-21-000120
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-04-13 19:53:51
Reporting Period:
2021-03-10
Accepted Time:
2021-04-13 19:53:51
Original Submission Date:
2021-03-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401708 Nanostring Technologies Inc NSTG Biological Products, (No Disgnostic Substances) (2836) 200094687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1575739 Bradley R Gray 530 Fairview Avenue N
Seattle WA 98109		 President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-10 8,631 $1.92 146,138 No 4 M Direct
Common Stock Acquisiton 2021-03-10 16,369 $6.72 162,507 No 4 M Direct
Common Stock Disposition 2021-03-10 10,261 $61.09 152,246 No 4 S Direct
Common Stock Disposition 2021-03-10 14,890 $62.02 137,356 No 4 S Direct
Common Stock Disposition 2021-03-10 6,082 $63.07 131,274 No 4 S Direct
Common Stock Disposition 2021-03-10 2,100 $63.88 129,174 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. On March 12, 2021, the Reporting Person filed a Form 4 which inadvertently misstated the number of shares held by the Reporting Person following the exercise of stock options and sale of shares of Common Stock reported on the Form 4. The number of shares reported in Column 5 of this Form 4/A reflects the corrected amounts of securities beneficially owned by the Reporting Person following the previously reported transactions as of the date of each such transaction.
  2. The sales reported by Mr. Gray were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2020.
  3. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $60.55 to $61.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $61.55 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $62.55 to $63.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  6. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $63.59 to $64.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.